The Evolving Landscape of Biomarkers for Immune Checkpoint Blockade in Genitourinary Cancers
In the past decade, immune checkpoint inhibitors (ICI) have been approved for treatment of genitourinary malignancies and have revolutionized the treatment landscape of these tumors. However, despite the remarkable success of these therapies in some GU malignancies, many patients’ tumors do not resp...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publishing
2024-05-01
|
| Colección: | Biomarker Insights |
| Acceso en línea: | https://doi.org/10.1177/11772719241254179 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|